Federal government gave Moderna $483 million in April to develop vaccine

REMINDER: New “vaccine czar” Moncef Slaoui owns 156,000 stock options in Moderna, a clear conflict of interest

Washington, DC – Patients Over Pharma released the following statement on reports that Moderna’s coronavirus vaccine is showing promising initial results.

“While this is fantastic news that hopefully leads to a successful vaccine, taxpayers deserve some assurances that the nearly $500 million they handed to Moderna will result in a vaccine that is affordable and accessible to every American and not simply another drug company profit engine putting more money into the pockets of shareholders like Trump’s new ‘vaccine czar.’”


back to top